Bausch Health Companies BHC
NYSE BHC
$6.13 -0.03 (-0.49%)
As of: Sep 10, 2026 · 11:56 AM EDT

Bausch Health Companies (BHC) Operating Margin (2009 - 2026)

Bausch Health Companies' (BHC) quarterly Operating Margin came in at 25.95% in Q2 2026, up 840.0% year-over-year from 2.76% in Q2 2025, and up 168.94% quarter-over-quarter from 37.64% in Q1 2026.

Analysis

Bausch Health Companies (BHC) Operating Margin (2009 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Operating Margin across 18 years of filings, most recently posting 25.95% for Q2 2026.

  • In Q2 2026, Operating Margin rose 840.0% year-over-year to 25.95%; the TTM figure through Jun 2026 stood at 8.14% (down 805.0% YoY), while the FY2025 annual figure was 17.66%, up 160.0% from the prior year.
  • Operating Margin came in at 25.95% for Q2 2026 at Bausch Health Companies, up from 37.64% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 25.95% in Q2 2026 to a low of 37.64% in Q1 2026.
  • Average Operating Margin over 5 years is 10.54%, with a median of 13.96% recorded in 2024.
  • Year-over-year, Operating Margin surged 2579 bps in 2023 and tumbled 4986 bps in 2026.
  • Over 5 years, Operating Margin stood at 10.76% in 2022, then jumped by 240 bps to 15.03% in 2023, then soared by 45 bps to 21.81% in 2024, then fell by 22 bps to 16.95% in 2025, then soared by 53 bps to 25.95% in 2026.
  • Per Business Quant data, the three most recent Operating Margin figures were 25.95% in Q2 2026, 37.64% in Q1 2026, and 16.95% in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.69 Bn 2.15 Bn -5.58%
2 Viatris 18.87 Bn 17.98 Bn 1.46 Bn 0.17%
3 Dr Reddys Laboratories 9.74 Bn 9.57 Bn 396.53 Mn 4.69%
4 Amneal Pharmaceuticals 5.41 Bn 5.28 Bn 334.51 Mn 16.30%
5 Bausch Health Companies 2.30 Bn 458.88 Mn 2.10 Bn 25.95%
6 Alvotech 1.53 Bn 1.39 Bn 2.56 Mn -134.08%
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 15.21%
8 Amphastar Pharmaceuticals 1.02 Bn 726.78 Mn 93.47 Mn 21.60%
9 Fennec Pharmaceuticals 393.81 Mn 352.56 Mn 17.15 Mn 9.72%
10 RedHill Biopharma 175.97 Mn 175.97 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.95%
Mar 31, 2026 -37.64%
Dec 31, 2025 16.95%
Sep 30, 2025 23.09%
Jun 30, 2025 17.55%
Mar 31, 2025 12.22%
Dec 31, 2024 21.81%
Sep 30, 2024 12.67%
Jun 30, 2024 16.19%
Mar 31, 2024 13.05%
Dec 31, 2023 15.03%
Sep 30, 2023 0.63%
Jun 30, 2023 19.01%
Mar 31, 2023 9.00%
Dec 31, 2022 -10.76%
Sep 30, 2022 11.93%
Jun 30, 2022 8.19%
Mar 31, 2022 14.86%
Dec 31, 2021 16.71%
Sep 30, 2021 27.19%